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Abstract
Background: Sudden infant death syndrome (SIDS) remains the leading cause of death among infants less than 1 year of
age. Disturbed expression of some neurotransmitters and their receptors has been shown in the central nervous system of
SIDS victims but no biological abnormality of the peripheral vago-cardiac system has been demonstrated to date. The
present study aimed to seek vago-cardiac abnormalities in SIDS victims. The cardiac level of expression of muscarinic
receptors, as well as acetylcholinesterase enzyme activity were investigated.
Methodology/Principal Findings: Left ventricular samples and blood samples were obtained from autopsies of SIDS and
children deceased from non cardiac causes. Binding experiments performed with [
3H]NMS, a selective muscarinic ligand, in
cardiac membrane preparations showed that the density of cardiac muscarinic receptors was increased as shown by a more
than doubled Bmax value in SIDS (n=9 SIDS versus 8 controls). On average, the erythrocyte acetylcholinesterase enzyme
activity was also significantly increased (n=9 SIDS versus 11 controls).
Conclusions: In the present study, it has been shown for the first time that cardiac muscarinic receptor overexpression is
associated with SIDS. The increase of acetylcholinesterase enzyme activity appears as a possible regulatory mechanism.
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Introduction
Sudden infant death syndrome (SIDS) is poorly understood and
unpredictable. By definition, it refers to death in an infant less than
1 year of age when rigorous postmortem analysis fails to reveal an
apparent cause. It remains the leading cause of death among
infants aged between 1 month and 1 year [1–2]. In USA, SIDS
accounted for 8.9% of all infant deaths, i.e. 7313 cases within the
period 1999–2001 [3]. In Germany, in 2004, about 13% of all
infant deaths, i.e. 394 cases, occurred suddenly and unexpectedly
[4]. A prospective Italian study including 34,442 newborns showed
that 0.7 % died from SIDS [5]. It has been shown that the
expression of several neurotransmitters and their receptors may be
disturbed in the central nervous system of SIDS victims [6–10].
Several lines of evidence support the hypothesis that vagal
stimulation might result from a central serotonin receptor
overexpression [11–12]. Nicotine exposure during pregnancy has
been proposed as the most common risk factor for SIDS [10–11].
To date, no biologic abnormality of the peripheral vago-cardiac
system has been demonstrated [13]. Looking for such biological
abnormalities, we assessed the cardiac muscarinic receptor
expression level and the erythrocyte acetylcholinesterase (AchE)
activity in tissue samples from children who died of SIDS
compared to infants deceased from non cardiac causes (control
group).
Materials and Methods
Human Tissues
Altogether 18 SIDS and 19 control infants were included in this
study. Left ventricular samples (50–100 mg) (9 SIDS, 8 controls)
and blood samples (9 SIDS, 11 controls) were obtained from
children who died when aged between 1 and 9 months of age.
SIDS was diagnosed according to the American Academy of
Pediatrics definition: infant death that remains unexplained after a
thorough case investigation, including performance of a complete
autopsy, examination of the death scene, and review of the clinical
history [2]. Infants with cardiac diseases (clinical history of heart
disease and/or cardiac tissue abnormalities) were not diagnosed as
SIDS and were not included in the control group. In the control
group, the causes of death were: asphyxia (n=5), infection (n=7),
dehydration (n=3), metabolic disease (n=1), shaken baby
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matched for gender (controls: 7F/12M; SIDS: 7F/11M) and age
(controls: 4.062.3 months; SIDS: 4.561.5 months). Autopsies
were carried out in the Service d’Anatomie Pathologique et
Me ´decine Le ´gale, Ho ˆpital Raymond Poincare ´ (Garches, France).
All autopsies, cardiac tissue examinations and tissue collections
were performed by the same pathologist (CR) betweeen 1997 and
2007. Procedures were conducted in accordance with the French
law (DGS/DH/225/2B, 1986, modified in 1987) and the
recommendations of the Haute Autorite ´ de Sante ´ on SIDS
handling. Informed parental consent for post-mortem examination
and tissue collection for research purposes was obtained in all
cases. All samples were analysed following a blinded procedure.
Radioligand Binding Experiments
Methods were adapted from Gies et al. [14–15]. All saturation
binding experiments were carried out at 25uC in 0.5 mL Tris
buffer (50 mM, pH 7.4) containing 10–15 mg of protein. Samples
were incubated for 90 min. Incubation was stopped by rapid
vacuum filtration over Whatman GF/C glass microfibre filters
(VWR International SAS, Strasbourg, France) presoaked with
polyethylenimine 0.3% in order to reduce non-specific binding to
the filters. Filters were washed twice with 4 mL of ice-cold
incubation buffer and transferred to 6 mL counting vials
containing 3 mL of scintillation cocktail (Ready Protein+
TM,
Beckman Coulter France SA, Roissy CDG, France). Radioactivity
was then counted in a liquid scintillation spectrometer (LS
6000SC; Beckman Instruments) with an efficiency of 45%.
Scatchard analysis of the saturation data (linear regression with
Excel Software) was used to yield the maximal specific binding
sites (Bmax; fmol mg
21 protein) and the affinity constant (Kd; nmol
L
21). Protein content was measured according to the method of
Bradford [16] using bovine c-globulin as standard.
The density of total muscarinic receptors was assessed using the
tritiated non-selective muscarinic receptor antagonist N-methyls-
copolamine ([
3H]NMS; 81.0 Ci mmol
21) added in 12 concentra-
tions ranging from 40 to 2000 pmol L
21. Non-specific binding was
determined in the presence of 1 mmol L
21 atropine.
AchE Enzyme Activity
AchE enzyme activity was measured in erythrocytes from
venous total blood samples collected on heparin according to an
enzymatic colorimetric assay as previously described [17].
Statistics
All values are expressed as mean 6 standard deviation (SD).
Unpaired t-tests were performed using the Mann-Whitney U test.
P values=0.05 were considered to be statistically significant.
Results
In order to evaluate possible abnormalities of the cardiac vagal
system involved in SIDS, the density of cardiac muscarinic
receptors and the AchE activity levels were assessed in samples
obtained from autopsied SIDS victims and compared to values
measured in infants deceased from other causes (except from
cardiac causes). In the latter (control group), cardiac muscarinic
receptor density ranged from 46.1 to 100.5 fmol mg
21 protein and
AchE activity ranged from 2.9 to 5.7 units mL
21 erythrocytes. In
the control group, both parameters were homogenous whatever
the cause of death. The total muscarinic receptor density in the
heart of children who died from SIDS was more than double that
found in samples from children who died from other causes
(171.0695.3 versus 74.5621.5 fmol mg
21 protein; Fig. 1). Of
note, values of muscarinic receptor density were above control in 8
out of 9 samples from SIDS (Fig. 1). The affinity constant Kd was
similar in both groups (0.37560.114 and 0.47660.308 nmol L
21
in controls and SIDS, respectively). Average erythrocyte AchE
activity was also significantly increased in SIDS victims (5.861
versus 4.661 units mL
21 erythrocytes; Fig. 2). In controls, the
older the infants were, the higher cardiac muscarinic receptor
density and AchE enzyme activity (Fig. 3). In contrast, the density
Figure 1. Total muscarinic receptors in hearts from control and
SIDS children. Total muscarinic receptor densities (Bmax; fmol mg
21
protein) were obtained from Scatchard analysis of the saturation data
using [
3H]NMS as radioligand. Binding conditions were as described in
Material and Methods. Each symbol represents one individual value;
hatched bar represents the highest control value. *: P=0.0137 versus
control.
doi:10.1371/journal.pone.0009464.g001
Figure 2. AchE enzyme activity in erythrocytes from control
and SIDS children. AchE enzyme activity was assayed colorimetrically
in erythrocyte hemolysates. Each symbol represents one individual
value; hatched bar represents the highest control value. *: P=0.0128
versus control.
doi:10.1371/journal.pone.0009464.g002
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Total muscarinic receptor densities (Bmax; fmol mg
21 protein) were obtained from Scatchard analysis of the saturation data using [
3H]NMS as
radioligand. AchE enzyme activity was assayed colorimetrically in erythrocyte hemolysates. Each symbol represents one individual value. (a) Total
cardiac muscarinic receptors and (b) Erythrocyte AchE enzyme activity in controls (open symbols) and SIDS (full symbols); the value in brackets
indicates the only SIDS case which did not fit the AchE/age correlation.
doi:10.1371/journal.pone.0009464.g003
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correlated with age in SIDS victims; only one case did not fit the
AchE/age correlation (in brackets in Fig. 3).
Discussion
In this study, we were seeking possible abnormalities in the
intra-cardiac part of the vagal system associated with SIDS. To
date, cholinergic abnormalities have been reported only in the
central nervous system of SIDS victims: reduced muscarinic
binding has been shown in the arcuate nucleus [7], a decrease in
choline acetyltransferase immunoreactivity, a specific marker of
the cholinergic neurons, has been observed in the brainstem [8]
and alterations in nicotinic binding have been observed in
brainstem nuclei of children exposed to maternal smoking during
pregnancy [10]. In animals, a dysregulation of the autonomic
balance toward vagal hyperactivity has been suggested as a
possible consequence of nicotine exposure during pregnancy
leading to SIDS [11]. Nevertheless, peripheral effectors of the
vagal system are exclusively muscarinic receptors and non-
neuronal cholinergic nicotinic receptors have not been detected
so far in human hearts. Therefore, we focussed our investigations
on muscarinic receptors only. We now show peripheral vago-
cardiac abnormalities - namely overexpression of muscarinic
receptors - in SIDS victims. Overexpression of cardiac muscarinic
receptors and increased AchE activity in erythrocytes from SIDS
were observed. All SIDS included in the present study were
diagnosed according to the American Academy of Pediatrics
definition, namely the clinically unexplainable death of an infant
less than 1 year of age. Among 18 samples, only 4 came from
infants older than 6 months, at which age social factors might
contribute. However, all these individuals exhibited muscarinic
disorders similar to the younger ones, suggesting that social factors,
if any, could not account for the biological disorders observed in
SIDS victims. The control group included infants deceased from
several causes, among which asphyxia. It may be argued that
hypoxia could modify the expression of the muscarinic receptors.
However, cardiac muscarinic receptor density and erythrocyte
AchE activity measured in these particular infants were not
different from those of the whole control group. The triple risk
model proposed by Filiano & Kinney [18] suggests that sudden
death results from three simultaneously occurring factors: an
underlying vulnerability, an exogenous stressor and being in a
critical developmental period. Our results suggest that overex-
pression of muscarinic receptors in the heart may represent one
aspect of vulnerability. Sleeping in the ventral position would then
act as the fatal trigger [19]. Further studies will determine the
developmental evolution of the muscarinic receptor abnormality
described here. A peak of SIDS has been observed between 2 and
3 months of age [2]; it will be of particular interest to seek whether
the vago-cardiac abnormalities that we are describing here are
more pronounced during this period of life. Our data afford parts
of an answer. Figure 3 demonstrates opposite evolution of cardiac
muscarinic density and AchE activity with age in SIDS victims
compared to controls, and suggests that the larger the alterations
in vagal regulation, the earlier the age of death. Moreover,
differences between controls and SIDS occur mostly before the age
of 5–7 months, and it is well known that 90% of SIDS occurs
within the 6 first postnatal months. At first glance, increases in
AchE activity appear paradoxical. Pharmacologically, AchE
upregulation may allow to oppose the increased muscarinic
receptor density in order to maintain the sympatho-vagal balance.
Thus, the primary cardiac abnormality is rather the overexpres-
sion of muscarinic receptors, whereas AchE upregulation is
possibly a consequence of the latter. Consistently with this
assumption, there was virtually no overlap between Bmax
individual values obtained from SIDS hearts compared with
controls (1/9), while there was a quite large overlap for AchE
activity (4/9). However, since cardiac and blood samples were
obtained from different sets of SIDS, cardiac muscarinic receptor
density could not be correlated with AchE activity. In SIDS
victims, the compensatory mechanism could be not efficient
enough to restore cardiac autonomic balance and prevent from
death.
In conclusion, we showed an overexpression of muscarinic
receptors in cardiac tissues from SIDS. It remains to be
demonstrated whether or not increased number of binding sites
reflects functional differences and whether or not such an
abnormality associated with vagal excessive activity might
contribute to SIDS. In addition, AchE activity level was above
control level in SIDS. Cardiac muscarinic receptor overexpression
may represent the biological vulnerability to SIDS evoked by
Malloy [20].
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